{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-011171","form_type":"8-K","ticker":"DYN","cik":"0001818794","company_name":"Dyne Therapeutics, Inc.","filed_at":"2022-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.479277+00:00","generated_at":"2026-06-25T04:51:29.610593+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Dyne Therapeutics shareholders elect Hurwitz and Kersten to board, ratify auditor","bullets":["Edward Hurwitz elected as Class II director: 20,392,039 for, 7,406,127 withheld, 3,170,612 broker non-votes.","Dirk Kersten elected as Class II director: 20,066,236 for, 7,731,930 withheld, 3,170,612 broker non-votes.","Ratified Deloitte & Touche as auditor for FY2022: 30,967,416 for, 362 against, 1,000 abstain.","Annual meeting held June 3, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-011171","json":"https://secwatch.observer/filing/0000950170-22-011171.json","markdown":"https://secwatch.observer/filing/0000950170-22-011171.md","text":"https://secwatch.observer/filing/0000950170-22-011171.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818794/000095017022011171/0000950170-22-011171-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818794/000095017022011171/dyn-20220603.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T04:51:29.610593+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}